Literature DB >> 20347009

Rare NRXN1 promoter variants in patients with schizophrenia.

Abhishek K Shah1, Nina M Tioleco, Karen Nolan, Joseph Locker, Katherine Groh, Catalina Villa, Pavla Stopkova, Erika Pedrosa, Herbert M Lachman.   

Abstract

Copy number variants (CNVs) affecting the neurexin 1 (NRXN1) gene have been found in a subgroup of patients with schizophrenia (SZ). NRXN1 expression is complex, with multiple alternative splice forms generated from two major transcripts; NRXN1alpha and NRXN1beta. The majority of CNVs in SZ are deletions affecting the proximal NRXN1alpha exons and promoter region. Rare chromosomal events are useful in understanding the genetic basis of complex psychiatric disorders since affected genes become feasible targets to analyze for more subtle genetic alterations. As a first step towards this goal, we resequenced the NRXN1alpha promoter region in 170 patients with SZ and a similar number of controls. Two rare mutations were identified in the patient population. One previously unknown single nucleotide polymorphism (SNP) was found in controls. Bioinformatics analysis suggests that binding to several transcription factors may be affected by the minor alleles. The findings suggest that in addition to chromosomal alterations disrupting the NRXN1alpha promoter, rare point mutations in the region may also be involved in SZ pathogenesis. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347009      PMCID: PMC2862389          DOI: 10.1016/j.neulet.2010.03.047

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

Review 1.  The neuroligin and neurexin families: from structure to function at the synapse.

Authors:  M-F Lisé; A El-Husseini
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

2.  Novel genes identified in a high-density genome wide association study for nicotine dependence.

Authors:  Laura Jean Bierut; Pamela A F Madden; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Ovide F Pomerleau; Gary E Swan; Joni Rutter; Sarah Bertelsen; Louis Fox; Douglas Fugman; Alison M Goate; Anthony L Hinrichs; Karel Konvicka; Nicholas G Martin; Grant W Montgomery; Nancy L Saccone; Scott F Saccone; Jen C Wang; Gary A Chase; John P Rice; Dennis G Ballinger
Journal:  Hum Mol Genet       Date:  2006-12-07       Impact factor: 6.150

3.  The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3.

Authors:  Kaiwen Ma; Shuqiu Zheng; Zhiyi Zuo
Journal:  J Biol Chem       Date:  2006-05-24       Impact factor: 5.157

4.  Genomewide suggestive linkage of opioid dependence to chromosome 14q.

Authors:  Herbert M Lachman; Cathy S J Fann; Michael Bartzis; Oleg V Evgrafov; Richard N Rosenthal; Edward V Nunes; Christian Miner; Maria Santana; Jebediah Gaffney; Amy Riddick; Chia-Lin Hsu; James A Knowles
Journal:  Hum Mol Genet       Date:  2007-04-04       Impact factor: 6.150

5.  Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.

Authors:  George Kirov; Dilihan Gumus; Wei Chen; Nadine Norton; Lyudmila Georgieva; Murat Sari; Michael C O'Donovan; Fikret Erdogan; Michael J Owen; Hans-Hilger Ropers; Reinhard Ullmann
Journal:  Hum Mol Genet       Date:  2007-11-06       Impact factor: 6.150

6.  Induction of GABAergic postsynaptic differentiation by alpha-neurexins.

Authors:  Yunhee Kang; XueZhao Zhang; Frederick Dobie; Huaiyang Wu; Ann Marie Craig
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

7.  Disruption of neurexin 1 associated with autism spectrum disorder.

Authors:  Hyung-Goo Kim; Shotaro Kishikawa; Anne W Higgins; Ihn-Sik Seong; Diana J Donovan; Yiping Shen; Eric Lally; Lauren A Weiss; Juliane Najm; Kerstin Kutsche; Maria Descartes; Lynn Holt; Stephen Braddock; Robin Troxell; Lee Kaplan; Fred Volkmar; Ami Klin; Katherine Tsatsanis; David J Harris; Ilse Noens; David L Pauls; Mark J Daly; Marcy E MacDonald; Cynthia C Morton; Bradley J Quade; James F Gusella
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

8.  Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.

Authors:  Francine M Benes; Benjamin Lim; David Matzilevich; John P Walsh; Sivan Subburaju; Martin Minns
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

9.  c-Myb is required for neural progenitor cell proliferation and maintenance of the neural stem cell niche in adult brain.

Authors:  Jordane Malaterre; Theo Mantamadiotis; Sebastian Dworkin; Sally Lightowler; Qing Yang; Mark I Ransome; Ann M Turnley; Nancy R Nichols; Nikla R Emambokus; Jon Frampton; Robert G Ramsay
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

10.  Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation.

Authors:  Irina Dudanova; Katsuhiko Tabuchi; Astrid Rohlmann; Thomas C Südhof; Markus Missler
Journal:  J Comp Neurol       Date:  2007-05-10       Impact factor: 3.215

View more
  6 in total

Review 1.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

2.  Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs.

Authors:  Xiaoli Chen; Yiping Shen; Feng Zhang; Colby Chiang; Vamsee Pillalamarri; Ian Blumenthal; Michael Talkowski; Bai-Lin Wu; James F Gusella
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

3.  Selected rapporteur summaries from the XX World Congress of Psychiatric Genetics, Hamburg, Germany, October 14-18, 2012.

Authors:  Heike Anderson-Schmidt; Olga Beltcheva; Mariko D Brandon; Enda M Byrne; Eric J Diehl; Laramie Duncan; Suzanne D Gonzalez; Eilis Hannon; Katri Kantojärvi; Iordanis Karagiannidis; Mark Z Kos; Eszter Kotyuk; Benjamin I Laufer; Katarzyna Mantha; Nathaniel W McGregor; Sandra Meier; Vanessa Nieratschker; Helen Spiers; Alessio Squassina; Geeta A Thakur; Yash Tiwari; Biju Viswanath; Michael J Way; Cybele C P Wong; Anne O'Shea; Lynn E DeLisi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-01-22       Impact factor: 3.568

4.  Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.

Authors:  Aristotle N Voineskos; Tristram A P Lett; Jason P Lerch; Arun K Tiwari; Stephanie H Ameis; Tarek K Rajji; Daniel J Müller; Benoit H Mulsant; James L Kennedy
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

5.  Sex-dependent novelty response in neurexin-1α mutant mice.

Authors:  Marijke C Laarakker; Niels R Reinders; Hilgo Bruining; Roel A Ophoff; Martien J H Kas
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

6.  Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors.

Authors:  Roopali Yadav; Subhash C Gupta; Brandon G Hillman; Jay M Bhatt; Dustin J Stairs; Shashank M Dravid
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.